Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Finasteride and dutasteride do not significantly change beard thickness in men.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.